US 11633377
Treatment of circadian rhythm disorders
granted A61KA61K31/00A61K31/05
Quick answer
US patent 11633377 (Treatment of circadian rhythm disorders) held by VANDA PHARMACEUTICALS INC. expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VANDA PHARMACEUTICALS INC.
- Grant date
- Tue Apr 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/00, A61K31/05, A61K31/15, A61K31/277